BioMimetic Therapeutics Inc. announced yesterday impressive data from randomized trials of its Augment Bone Graft product, showing it performed well in comparison with material harvested via autograft. The
release is here. At 4:20 p.m. CT today, the stock was up about
20 percent over day-earlier.
No comments:
Post a Comment